Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (51-60 of 272) with videos related to

Pageof 28
Sort By:
Lancet (London, England)|December 31, 2003
Viral hepatitis BChing Lung Lai, Vlad Ratziu, Man-Fung Yuen, et al.
Journal of Hepatology|March 29, 2003
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?Thierry Poynard, Dominique Thabut, Ariane Chryssostalis, et al.
Journal of Hepatology|December 4, 2003
Fibrogenic impact of high serum glucose in chronic hepatitis CVlad Ratziu, Mona Munteanu, Fréderic Charlotte, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 17, 2007
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis CRobert P Myers, Djamila Messous, Thierry Poynard, et al.
Human Pathology|April 24, 2010
A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis CFréderic Charlotte, Gilles Le Naour, Carole Bernhardt, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Screening studies of transient elastography and FibroTest in the general populationThierry Poynard, Valentina Peta, Priscilla Pollo-Flores, et al.
Gastroenterologie Clinique Et Biologique|November 25, 2003
[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?]Vlad Ratziu, Sophie Le Calvez, Luminita Bonyhay, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirinThierry Poynard, John McHutchison, Michael Manns, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Non invasive markers using for the assessment of fibrosis in hepatitis C]Jean-Pierre Zarski, Pierre Bedossa, Jean-Pierre Bronowicki, et al.
Plos One|August 12, 2010
Hirsch index and truth survival in clinical researchThierry Poynard, Dominique Thabut, Mona Munteanu, et al.
Pageof 28

Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
Lancet (London, England)|December 31, 2003
Viral hepatitis BChing Lung Lai, Vlad Ratziu, Man-Fung Yuen, et al.
Journal of Hepatology|March 29, 2003
Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?Thierry Poynard, Dominique Thabut, Ariane Chryssostalis, et al.
Journal of Hepatology|December 4, 2003
Fibrogenic impact of high serum glucose in chronic hepatitis CVlad Ratziu, Mona Munteanu, Fréderic Charlotte, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 17, 2007
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis CRobert P Myers, Djamila Messous, Thierry Poynard, et al.
Human Pathology|April 24, 2010
A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis CFréderic Charlotte, Gilles Le Naour, Carole Bernhardt, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Screening studies of transient elastography and FibroTest in the general populationThierry Poynard, Valentina Peta, Priscilla Pollo-Flores, et al.
Gastroenterologie Clinique Et Biologique|November 25, 2003
[Hepatocellular carcinoma and non alcoholic steatohepatitis: are we looking at the tip of the iceberg?]Vlad Ratziu, Sophie Le Calvez, Luminita Bonyhay, et al.
Hepatology (Baltimore, Md.)|July 29, 2003
Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirinThierry Poynard, John McHutchison, Michael Manns, et al.
Gastroenterologie Clinique Et Biologique|October 30, 2007
[Non invasive markers using for the assessment of fibrosis in hepatitis C]Jean-Pierre Zarski, Pierre Bedossa, Jean-Pierre Bronowicki, et al.
Plos One|August 12, 2010
Hirsch index and truth survival in clinical researchThierry Poynard, Dominique Thabut, Mona Munteanu, et al.
Pageof 28